
Clinical Research at MENA
Challenges and Solutions
Herausgegeben: Özdener, Fatih
Versandkostenfrei!
Versandfertig in 6-10 Tagen
37,75 €
inkl. MwSt.
PAYBACK Punkte
0 °P sammeln!
The meaning of Clinical Trials for humans has recently changed significantly,"evolved", so to speak. In today's environment, where ethical validity is much morestrictly controlled, this meaning is far beyond "human drug testing" and much closerto the "therapeutic goal". The number of clinical trials in western countries that haveperceived this change has increased rapidly and continues to increase. Althoughthe number of clinical studies in the MENA region is increasing day by day, it is stillfar from its potential. Among the reasons for this are legal, technological, ethical,epidemiological, e...
The meaning of Clinical Trials for humans has recently changed significantly,
"evolved", so to speak. In today's environment, where ethical validity is much more
strictly controlled, this meaning is far beyond "human drug testing" and much closer
to the "therapeutic goal". The number of clinical trials in western countries that have
perceived this change has increased rapidly and continues to increase. Although
the number of clinical studies in the MENA region is increasing day by day, it is still
far from its potential. Among the reasons for this are legal, technological, ethical,
epidemiological, educational and economic factors. This book presents both the
difficulties encountered in conducting clinical trials in MENA and suggestions for
solving these difficulties.
"evolved", so to speak. In today's environment, where ethical validity is much more
strictly controlled, this meaning is far beyond "human drug testing" and much closer
to the "therapeutic goal". The number of clinical trials in western countries that have
perceived this change has increased rapidly and continues to increase. Although
the number of clinical studies in the MENA region is increasing day by day, it is still
far from its potential. Among the reasons for this are legal, technological, ethical,
epidemiological, educational and economic factors. This book presents both the
difficulties encountered in conducting clinical trials in MENA and suggestions for
solving these difficulties.